SLC6A17
protein-codingsolute carrier family 6 member 17, the group of Solute carrier family 6
Gene summary
The protein encoded by this gene is a member of the SLC6 family of transporters, which are responsible for the presynaptic uptake of most neurotransmitters. The encoded vesicular transporter is selective for proline, glycine, leucine and alanine. In mouse, the strongest expression of this gene was in cortical and hippocampal tissues where expression increased during embryonic brain development and peaked postnatally. Defects in this gene cause a form of autosomal recessive intellectual disability. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~51.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014559
Submitter: G2P
Inheritance Pattern: Unknown
Disease ID:MONDO:0005090
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014559
Submitter: Illumina
Inheritance Pattern: AR
Disease ID:MONDO:0014559
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014559
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014559
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014559
Submitter: ClinGen
Th*e SLC6A17 g*ene was first reported in association with autosomal recessive intellectual disability type 48 in 2015 (Iqbal Z et al., PMID: 25704603). To date, at least five affected individuals from two unrelated families have been described in the literature (family 1 with two probands and family 2 with three probands). Across two publications, three missense variants have been reported; however, detailed functional characterization has been performed for only two variants, which were included in this curation (Iqbal Z et al., PMID: 25704603). Overall, functional data support a loss-of-function disease mechanism. This gene-disease relationship is also supported by animal models where studies demonstrate that loss of SLC6A17 impairs glutamine transport into presynaptic compartments. Furthermore, both Slc6a17 knockout mice and mice homozygous for the P633R patient variant show significantly reduced glutamine levels in synaptic vesicles (Jiao X et al., PMID: 37440432). Additionally, NTT4 (SLC6A17) knockout mice exhibit impaired retention of conditioned memory associations when conditioned and unconditioned stimuli are separated by a longer temporal gap which recapitulates the phenotypes described in the literature (Nicoli AL et al., PMID: 40436200). In summary, there is moderate evidence supporting a gene–disease relationship between SLC6A17 and intellectual disability type 48. This classification was approved by the ClinGen IEM GCEP at the meeting on February 13th, 2026 (SOP Version 12).
Inheritance Pattern: AR
Disease ID:MONDO:0014559
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC6A17 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001010898.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 24 | 1 | 26 | ||
| missense | 2 | 94 | 8 | 1 | 105 | |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 2 | 0 | 99 | 32 | 2 | 135 |
Highest pathogenic variant AF is 0.0000041044163
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001010898.1 | 11 | MANE Select | |
| Ensembl | ENSP00000330199.3 | 11 | MANE Select | |
| Ensembl | ENSP00000543522.1 | 11 | Standard | |
| Ensembl | ENSP00000543522.1 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Nuclear Receptors Meta-Pathway
- NRF2 pathway
Biological Process
- brain development
- neutral amino acid transport
- glycine transport
- leucine transport
- proline transport
Molecular Function
- neurotransmitter:sodium symporter activity
Cellular Component
- integral component of plasma membrane
- synaptic vesicle
- cell junction
- integral component of synaptic vesicle membrane
- glutamatergic synapse
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000331565
- Coding exons
- 11
- Length
- 51717
- Individuals with no LoFs
- 125737
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 11
- Defined
- 125748
- p
- 0.0000437
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.39 | 313 | 456 | 0.686 | 0.0000279 | 4752 |
| Missense (PolyPhen) | 116 | 192.89 | 0.60137 | 2004 | ||
| Synonymous | 1.05 | 181 | 200 | 0.905 | 0.0000133 | 1470 |
| Loss of Function | 3.86 | 6 | 28.0 | 0.214 | 0.00000132 | 321 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00027 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000070 | 0.000070 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Functions as a sodium-dependent vesicular transporter selective for proline, glycine, leucine and alanine. In contrast to other members of this neurotransmitter transporter family, does not appear to be chloride-dependent (By similarity). {ECO:0000250|UniProtKB:P31662}.;
- Disease
- DISEASE: Mental retardation, autosomal recessive 48 (MRT48) [MIM:616269]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT48 patients show moderate to severe intellectual disability and additional features including progressive tremor, speech impairment, and sometimes behavioral problems. {ECO:0000269|PubMed:25704603}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- LoFtool
- 0.244
- RVIS EVS
- -0.57
- RVIS percentile EVS
- 18.9
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.236
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |